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INTRODUCTION
Superlatives are tactics used by 
journalists to inflate the benefit of drugs 
and medical devices. 
News articles using these exaggerations 
could distort the perceptions of a drug’s 
effectiveness on health care providers 
and consumers. 
Superlative use is of particular 
importance when readers look beyond 
medical literature and use news articles 
to seek medical information. 
The current extent of superlative use in 
news articles with cardiovascular drugs 
is not currently known. 
OBJECTIVES
Investigate the use of superlatives and 
specific enticing language in current 
news articles on cardiovascular drugs.
METHODS
We searched Google News for 10 
superlative terms, along with the search 
term “heart drug”. 
We searched for articles published over 
a five-day period (September 1, 2019 to 
September 5th, 2019). 
Articles were screened for relevance to 
cardiac drugs and whether the 
superlative was used in reference to the 
drug. 
Two of us (DJ and AD) reviewed and 
extracted data for all news articles in a 
duplicate, blinded fashion. 
The extracted data elements included: 
Drug described by the superlative
Drug class
FDA Drug Approval
If the article described clinical or 
preclinical data
The news outlet
If news article authors were journalists, 
healthcare providers, or other. 
Following data extraction, the two 
investigators met and resolved 
discrepancies. 
If a discrepancy could not be resolved, a 
third investigator (MV) was available for 
adjudication. 
CONCLUSION
We demonstrated that superlatives are 
commonly used in news articles in 
regards to cardiovascular drugs. 
Other studies have demonstrated the 
use of superlatives in oncology news 
articles, though this is the first of its kind 
exploring superlatives use in cardiology 
news articles. 
News journalists may not correctly 
understand the magnitude of clinical 
benefit of particular drugs and may, 
thus, use superlatives unjustifiably. 
Limitations of our study include a short 
time period for which data were 
collected and a small sample size of the 
included news articles. Further research 
exploring superlative use in cardiology 
and in other fields of medicine is 
warranted.
Superlatives may influence consumers 
and health care providers’ perceptions 
of a specific drug and its relation to 
current medical care. 
We found that the majority of our news 
articles contain superlatives, thus we 
recommend readers exercise caution 
that their opinion not be clouded by 
these exaggerations.
RESULTS
Our initial search resulted in 59 news articles from 53 
different news outlets. 
Twenty-three articles met inclusion criteria and were 
included in our final data set. 
We found 29 instances of superlative use in 23 of the 
included articles. 
Eleven drugs from 7 drug classes were associated with 
superlative use with 1 article not mentioning the drug 
name. 
The most common drug associated with superlative use 
was Inclisiran, a PCSK9 inhibitor.
Over a quarter of the drugs did not have FDA approval
The most frequent superlative used was ‘Game-
Changer’
The superlatives “Marvel” and “Miracle” yielded no 
results. The majority of the authors were journalists 
while only one article was written by a physician.
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SUPERLATIVES USED
Breakthrough
Game Changer
Miracle
Cure
Home Run
Revolutionary
Transformative
Life-Saving
Groundbreaking 
Marvel
